FDA.reportPublic FDA data

Sorilux 0.005 % Topical Foam

RxCUI
1020039
RxNorm name
Sorilux 0.005 % Topical Foam
Display name
Sorilux 0.005 % Topical Foam
Full name
Sorilux 0.005 % Topical Foam
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SORILUXCALCIPOTRIENEMayne Pharma51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe2024-05-09Warnings, Adverse reactionsExact identifier
rxcui: 1020039

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
51f208d0-7b3f-44cc-8bed-92fa3d2e7bbeSorilux 0.005 % Topical Foam [PSN] · calcipotriene 0.05 MG/ML Topical Foam [Sorilux] [SBD] · Sorilux 0.005 % Topical Foam [SY] · Sorilux 0.05 MG/ML Topical Foam [SY]47These highlights do not include all the information needed to use SORILUX safely and effectively. See full prescribing information for SORILUX. SORILUX (calcipotriene) foam, for topical use Initial U.S. Approval: 199320240509